Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin for Early Rehabilitation After Ischemic Stroke
NCT07043686Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jun 2025
- Primary completion
- Jul 2027
- Modality
- Native Peptides
- Countries
- 1
01
Overview
Open-label trial of cerebrolysin in ischemic stroke (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Action Research Arm Test at 90 days. Started Jun 2025; status: recruiting.
02
Drugs
cerebrolysin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07043686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07043686.